BioSpace News Archive

BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced the BioButton™ was named the Best New Monitoring Solution in the fifth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough,

DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Rick Anderson, President and General Manager of North America, will participate in the Vatican’s Pontifical Council for Culture and The Cura Foundation’s Fifth International Vatican Conference.

MY01 Inc. is on a mission to empower healthcare professionals with the ability to pre-empt severe medical conditions, improving patient outcomes. MY01 inc. today announced U.S. Food and Drug Administration 510(k) clearance for the MY01 Continuous Compartment Pressure Monitor with full Bluetooth capabilities.

Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the Company will release its first quarter 2021 financial results before the market opens on Thursday, May 13, 2021

Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that Meridian Health Services Network (Meridian HSN) will offer AditxtScore™ for COVID-19 to its network of healthcare provider partners.

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, today reported business highlights and financial results for the first quarter ended March 31, 2021 .

Amyris, Inc., a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, announced financial results for its first quarter ended March 31, 2021.

LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced the appointment of Josh Hamermesh as an independent board director.

DarwinHealth, a New York City-based biotechnology company, today announced a scientific research collaboration with Bristol-Myers Squibb Company (NYSE: BMY).

Company partners with Rhinostics and P&G subsidiary iMFLUX to help increase access to advanced testing tools for COVID-19, influenza and other diseases